Feedback / Questions
KME-0584 - Kurome
https://www.businesswire.com/news/home/20240215544888/en/CORRECTING-and-REPLACING-Kurome-Therapeutics-Announces-FDA-Clearance-of-Investigational-New-Drug-IND-Application-for-KME-0584-for-the-Treatment-of-Acute-Myeloid-Leukemia-AML-and-High-Risk-Myelodysplastic-Syndromes-MDS
Feb 15, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next